Other Assets, Current in USD of GUIDED THERAPEUTICS INC from Q4 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Guided Therapeutics Inc quarterly Other Assets, Current history and change rate from Q4 2010 to Q3 2025.
  • Guided Therapeutics Inc Other Assets, Current for the quarter ending 30 Sep 2025 was $123K, a 41.7% decline year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Change (%)

GUIDED THERAPEUTICS INC Quarterly Other Assets, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $123K -$88K -41.7% 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 $23K -$89K -79.5% 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 $61K -$95K -60.9% 31 Mar 2025 10-Q 15 May 2025
Q4 2024 $173K +$10K +6.14% 31 Dec 2024 10-Q 13 Nov 2025
Q3 2024 $211K +$19K +9.9% 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 $112K +$21K +23.1% 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 $156K +$35K +28.9% 31 Mar 2024 10-Q 14 May 2024
Q4 2023 $163K +$26K +19% 31 Dec 2023 10-K 31 Mar 2025
Q3 2023 $192K +$23K +13.6% 30 Sep 2023 10-Q 13 Nov 2023
Q2 2023 $91K +$32K +54.2% 30 Jun 2023 10-Q 10 Aug 2023
Q1 2023 $121K -$332K -73.3% 31 Mar 2023 10-Q 15 May 2023
Q4 2022 $137K -$240K -63.7% 31 Dec 2022 10-K 28 Mar 2024
Q3 2022 $169K -$4K -2.31% 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 $59K -$2K -3.28% 30 Jun 2022 10-Q 15 Aug 2022
Q1 2022 $453K +$414K +1062% 31 Mar 2022 10-Q 16 May 2022
Q4 2021 $377K +$292K +344% 31 Dec 2021 10-K 30 Mar 2023
Q3 2021 $173K +$63K +57.3% 30 Sep 2021 10-Q 15 Nov 2021
Q2 2021 $61K +$20K +48.8% 30 Jun 2021 10-Q 18 Aug 2021
Q1 2021 $39K +$3K +8.33% 31 Mar 2021 10-Q/A 18 Aug 2021
Q4 2020 $85K +$15K +21.4% 31 Dec 2020 10-K 30 Mar 2022
Q3 2020 $110K +$4K +3.77% 30 Sep 2020 10-Q/A 05 Nov 2020
Q2 2020 $41K +$39K +1950% 30 Jun 2020 10-Q 20 Aug 2020
Q1 2020 $36K $0 0% 31 Mar 2020 10-Q 07 Jul 2020
Q4 2019 $70K +$1K +1.45% 31 Dec 2019 10-K 07 Apr 2021
Q3 2019 $106K -$2K -1.85% 30 Sep 2019 10-Q 09 Mar 2020
Q2 2019 $2K -$39K -95.1% 30 Jun 2019 10-Q 11 Feb 2020
Q1 2019 $36K -$54K -60% 31 Mar 2019 10-Q 11 Jul 2019
Q4 2018 $69K -$42K -37.8% 31 Dec 2018 10-K 20 Apr 2020
Q3 2018 $108K -$71K -39.7% 30 Sep 2018 10-Q 14 Nov 2018
Q2 2018 $41K 30 Jun 2018 10-Q 14 Aug 2018
Q1 2018 $90K -$116K -56.3% 31 Mar 2018 10-Q 21 May 2018
Q4 2017 $111K -$148K -57.1% 31 Dec 2017 10-K 08 May 2019
Q3 2017 $179K 30 Sep 2017 10-Q 20 Nov 2017
Q1 2017 $206K 31 Mar 2017 10-Q 22 May 2017
Q4 2016 $259K -$521K -66.8% 31 Dec 2016 10-K/A 20 Apr 2018
Q4 2015 $780K +$681K +688% 31 Dec 2015 10-K 22 Mar 2017
Q3 2015 $979K +$548K +127% 30 Sep 2015 10-Q 12 Nov 2015
Q2 2015 $28K +$15K +115% 30 Jun 2015 10-Q 13 Aug 2015
Q1 2015 $52K +$4K +8.33% 31 Mar 2015 10-Q 13 May 2015
Q4 2014 $99K -$2K -1.98% 31 Dec 2014 10-K 15 Mar 2016
Q3 2014 $431K +$246K +133% 30 Sep 2014 10-Q 12 Nov 2014
Q2 2014 $13K -$102K -88.7% 30 Jun 2014 10-Q 13 Aug 2014
Q1 2014 $48K -$199K -80.6% 31 Mar 2014 10-Q 15 May 2014
Q4 2013 $101K -$97K -49% 31 Dec 2013 10-K 25 Mar 2015
Q3 2013 $185K +$66K +55.5% 30 Sep 2013 10-Q 13 Nov 2013
Q2 2013 $115K +$76K +195% 30 Jun 2013 10-Q 14 Aug 2013
Q1 2013 $247K +$202K +449% 31 Mar 2013 10-Q 14 May 2013
Q4 2012 $198K +$144K +267% 31 Dec 2012 10-K 26 Mar 2014
Q3 2012 $119K 30 Sep 2012 10-Q 13 Nov 2012
Q2 2012 $39K +$17K +77.3% 30 Jun 2012 10-Q/A 24 Aug 2012
Q1 2012 $45K 31 Mar 2012 10-Q 14 May 2012
Q4 2011 $54K +$24K +80% 31 Dec 2011 10-K 27 Mar 2013
Q2 2011 $22K 30 Jun 2011 10-Q 14 Nov 2011
Q4 2010 $30K 31 Dec 2010 10-K 28 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.